Intercept’s Ocaliva approved in EU for liver disease
Potential liver blockbuster gets EU licence.
X
Intercept’s Ocaliva approved in EU for liver disease
https://pharmaphorum.com/news/intercepts-ocaliva-approved-eu-liver-disease/
Potential liver blockbuster gets EU licence.